compound semaglutide safe Compounded Semaglutide: Safety & Regulation Guide TGA issues safety alert after

The compound is designed to activate three hormone receptors simultaneously: GLP-1, GIP, and glucagon receptors

Beyond T2DM, the Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes trial is assessing whether GLP-1 RAs can meaningfully reduce MACE, HF hospitalizations, and other cardiovascular endpoints in patients with type 1 diabetes, a population generally underrepresented in cardiovascular prevention studies [66]

The dysesthesia signal needs monitoring

Retatrutide appears to provide similar benefits while adding additional metabolic effects through GIP and glucagon receptor activation